Abstract
22nd Brazilian Diabetes Society Congress
Highlights
A reduced number of trials evaluated the effects of SGLT2 inhibitors on glucose pattern by continuous glucose monitoring (CGM), but neither compared these effects with other class of antidiabetics
Knowing the important antioxidant capacity of beans, we evaluated whether this profile results in antioxidant effect in vivo, since the in vitro study does not take into account the bioavailability of these compounds, their metabolism, tissue retention and cellular activity
Diabetic cardiomyopathy is characterized by ventricular diastolic/systolic dysfunction resulting from a malfunction of the proteins responsible for maintaining calcium (SERCA2a, PLP, FKBP 12.6) reducing the contractile performance of the heart, and physical exercise is one of the methods to reduce the progress of cardiomyopathy in diabetes
Summary
A reduced number of trials evaluated the effects of SGLT2 inhibitors on glucose pattern by CGM, but neither compared these effects with other class of antidiabetics. Methodology: Cross-sectional and observational study conducted among 33 patients diagnosed with post-transplant diabetes, male and female, aged between 20 and 80 years, treated at the Nutrition service of a specialized outpatient clinic. Objective: To study outcomes related to glycemic control in patients undergoing bariatric surgery, as well as factors capable of predicting a greater chance of achieving total or partial remission of diabetes mellitus. Conclusions: In this cohort with a significant number of women with GDM, where postpartum reclassification was higher than the average observed in our country, we observed a significantly higher risk of developing postpartum DM2 in patients who needed insulin to control diabetes during pregnancy. Conclusions: This population analysis showed that the patients already had moderate sypmtoms of DPN at the first evaluation of diabetic neuropathy (even with low occurrence of neurologic alterations), besides high prevalence of other microvascular complications.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
